Cortex
Cortex, a California-based software company, innovates precise, simple, and fast AFib assessment and treatment solutions.
Founded
2023Cortex, a California-based software company, innovates precise, simple, and fast AFib assessment and treatment solutions.
Cortex, founded in Santa Clara, California, is a software company dedicated to revolutionizing the diagnosis and treatment of atrial fibrillation (AFib). Their core mission is to provide precise, simple, and rapid solutions for AFib assessment and treatment. Cortex's flagship product, the OptiMap™ System, leverages AI to offer advanced electrographic flow (EGF) mapping, enabling physicians to gain deeper insights into each patient's disease pathophysiology. This innovative platform aims to transform how atrial arrhythmias are diagnosed and treated, focusing on delivering personalized and effective healthcare solutions.
Cortex has assembled a team of highly skilled engineers and clinical experts to drive its mission forward. The company has achieved significant milestones, including the (k) clearance of the OptiMap™ System, underscoring its commitment to regulatory compliance and clinical efficacy. By integrating cutting-edge technology with clinical expertise, Cortex has made a notable impact on the medical community, offering tools that enhance the precision and speed of AFib treatment. Their contributions are poised to improve patient outcomes and set new standards in cardiac care.
Companies similar to Cortex include CoreMap, Ablacon, Atriomx and CardioPhi.
Cortex was founded in 2023.
Cortex's headquarters is located in Santa Clara, CA, US.
Cortex's most recent funding round was for $90M (USD) in December 2023.
As of Dec 7, 2023, Cortex has disclosed funding of $90M (USD). Undisclosed round amounts are excluded.
Cortex has 30 employees as of Feb 4, 2024.
